COVID-19 funding for Brussels-based enterprises

Brussels-based companies will be funded to develop or implement innovative vaccines, treatments, medical devices and medical equipment.

Amount
Up to 80% of project costs
Agency or Funder
Eligibility (if available)

Companies with at least one operating base in Brussels

Foreign participation? (where known)
No
Country
Date of announcement
Date application deadline